News

NRx Pharmaceuticals a clinical-stage biopharmaceutical company (NRx), today announced that the US Food and Drug Administration (FDA) has declined to issue an Emergency Use Authorization…
Read More...

Yokogawa Electric Corporation  announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess…
Read More...

Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of…
Read More...

Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a…
Read More...

Venatorx Pharmaceuticals announced that it has entered into a Research Collaboration and License Agreement with Roche to discover, characterize and develop new small molecule inhibitors…
Read More...

Resverlogix Corp. a world leader in epigenetics or gene regulation, is pleased to announce that it is in active discussions with the Kingdom of Morocco’s Ministry of Health for possible…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the completion of its rolling…
Read More...

WuXi Biologics a global company with leading open-access biologics technology platforms, announced it has successfully launched the GMP operation of its new drug product facility…
Read More...

Ubiquigent Limited announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide Bristol…
Read More...

TFF Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF)…
Read More...

Agomab Therapeutics NV (‘Agomab’) announced that it has entered into a definitive agreement under which it will acquire Origo Biopharma S.L., a Spanish clinical-stage biotechnology…
Read More...

Pfizer Inc. and BioNTech SE  announced that the U.S. government has purchased 50 million more doses of the companies’ COVID-19 vaccine. The U.S. will receive these additional doses to…
Read More...

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire GammaDelta Therapeutics Limited (“GammaDelta”), a company focused on exploiting the unique…
Read More...

Sorrento Therapeutics, Inc. announced positive preliminary results from two Phase 2 studies designed to identify the hospitalized patient population suffering from COVID-19-induced…
Read More...

WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by Health Canada for its drug substance…
Read More...

Signet Therapeutics and XtalPi Inc., a physics-based, AI-powered drug R&D company, announced the expansion of their AI drug discovery collaboration to include a new first-in-class…
Read More...

Immunai, a New York-based biotech company, announced a $215M Series B, increasing the company’s total funding to date to $295M. The new capital will be used to expand Immunai’s “drug…
Read More...

Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel first-in-class therapies for patients with urea cycle disorders…
Read More...

Vertex Pharmaceuticals Incorporated and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new…
Read More...

Teva Pharmaceutical Industries Ltd. and MODAG GmbH announced a strategic collaboration on the exclusive worldwide licensing and development of MODAG's lead compound anle138b and a…
Read More...